Care Bare Rx vs Eden
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Care Bare Rx
Best for LGBTQ+-inclusive compounded GLP-1 telehealthStarting at $199/mo
Eden
Best for mainstream telehealth GLP-1 accessStarting at $189/mo
Side-by-Side Comparison
| Feature | Care Bare Rx | Eden |
|---|---|---|
| Overall Score | ✓7.4/10 | 7.2/10 |
| Starting Price | $199/mo | ✓$189/mo |
| Editorial Rating | ✓3.7 ★ /5 | 3.6 ★ /5 |
| Features | ✓6 features | 3 features |
| States Available | 0 | ✓50 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | ✓ Yes | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
Care Bare Rx
Pros
- ✓Explicit LGBTQ+-inclusive, 'self-care with pride' positioning — one of the few GLP-1 telehealth brands with this framing
- ✓All 50 states + Puerto Rico coverage
- ✓Offers both compounded options ($199/mo) and brand-name Ozempic ($705/mo) — unusual flexibility in the compounded-first telehealth segment
- ✓Same named medical team as Breeze Meds and Synergy Rx: Dr. Ana Lisa Carr MD (NPI 1689841744) and Dr. Kelly Tenbrink MD (NPI 1346482684)
- ✓Four named 503A pharmacy partners (Belmar, Strive, Epiq Scripts, Casa Pharma Rx)
- ✓No FDA warnings or litigation on record
Cons
- ✗Runs on the same Lion MD clinician network and the same 4 compounding pharmacies as Breeze Meds and Synergy Rx — the three brands are white-labeled storefronts on top of one underlying operation, not three independent providers
- ✗Compounded medications are not FDA-approved
- ✗Despite the LGBTQ+ positioning, no formal gender-affirming care pathway or HRT integration is mentioned — the inclusive framing is editorial rather than a clinical specialty
- ✗Limited accreditation transparency beyond LegitScript claim — no PCAB/ACHC seal on site
- ✗Pharmacy partners are named but per-batch third-party testing and accreditation details are not independently disclosed
Eden
Pros
- ✓Both semaglutide and tirzepatide available
- ✓Compounded GLP-1 access
Cons
- ✗Limited public information on program details
Our Verdict
Care Bare Rx edges out Eden with a higher overall score of 7.4/10 and is particularly strong for LGBTQ+-inclusive compounded GLP-1 telehealth. Eden remains a solid alternative, especially if you're looking for mainstream telehealth GLP-1 access.
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.